It has an important role in angiogenesis (Masiero et al., 2013; Serban et al., 2015) and higher ELTD1 expression is associated with the vasculature of a number of tumour types and resistance to anti‐angiogenic therapy (Kan et al., 2018; Masiero et al., 2013; Niinivirta et al., 2020). The gene discussed is ADGRL4; the disease is neoplasm.